Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-28

Clinical Trial Update: Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effect of epoetin beta on renal function within 30 days after kidney transplantation. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • epoetin beta (epoetin beta)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Kidney Failure | Phase 3 | Status: COMPLETED